VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 222 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $322 | -70.8% | 34,382 | -23.6% | 0.00% | -100.0% |
Q2 2023 | $1,104 | +24.5% | 45,000 | +18.0% | 0.00% | 0.0% |
Q1 2023 | $887 | -54.3% | 38,135 | -50.3% | 0.00% | -66.7% |
Q4 2022 | $1,942 | -99.9% | 76,720 | +2.4% | 0.00% | +50.0% |
Q3 2022 | $1,445,000 | -28.7% | 74,941 | -5.8% | 0.00% | -33.3% |
Q2 2022 | $2,027,000 | +82.0% | 79,595 | +83.8% | 0.00% | +200.0% |
Q1 2022 | $1,114,000 | -38.6% | 43,317 | +0.1% | 0.00% | -50.0% |
Q4 2021 | $1,813,000 | -4.1% | 43,290 | -0.3% | 0.00% | 0.0% |
Q3 2021 | $1,890,000 | -23.1% | 43,422 | -16.4% | 0.00% | -33.3% |
Q2 2021 | $2,457,000 | -1.2% | 51,958 | +7.1% | 0.00% | 0.0% |
Q1 2021 | $2,487,000 | +91.5% | 48,500 | 0.0% | 0.00% | +200.0% |
Q4 2020 | $1,299,000 | -22.0% | 48,500 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $1,665,000 | -4.4% | 48,500 | +14.1% | 0.00% | 0.0% |
Q2 2020 | $1,741,000 | +519.6% | 42,500 | +418.3% | 0.00% | – |
Q1 2020 | $281,000 | +172.8% | 8,200 | 0.0% | 0.00% | – |
Q4 2019 | $103,000 | – | 8,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |